XML 76 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EARNING (LOSS) PER SHARE
12 Months Ended
Dec. 31, 2023
EARNING (LOSS) PER SHARE  
EARNING (LOSS) PER SHARE

26.  EARNING (LOSS) PER SHARE

Basc and diluted earning (loss) per share for each of the years presented were calculated as follows:

For the years ended December 31, 

2021

2022

2023

    

RMB

    

RMB

    

RMB

Numerator:

Net income (loss)

 

515,101

 

(761,994)

 

(2,597,169)

Net income attributable to noncontrolling interest

 

(15,003)

 

(13,958)

 

(46,667)

Net income (loss) attributable to the Company

 

500,098

 

(775,952)

 

(2,643,836)

Dividend distribution to perpetual convertible preferred shareholders

(5,831)

 

 

Adjusted net income (loss) attributable to ordinary shareholders - Basic

494,267

(775,952)

(2,643,836)

Changes in the fair value of financial liabilities

(829,149)

Adjusted interest for convertible promissory notes

9,703

Adjusted net loss attributable to ordinary shareholders -Diluted

 

(325,179)

(775,952)

(2,643,836)

Denominator:

    

  

    

  

    

  

Weighted average number of shares outstanding—basic

865,352,554

886,817,620

901,143,138

Weighted average number of shares outstanding—diluted

911,591,433

886,817,620

901,143,138

Earning (loss) per share—Basic:

 

 

 

Net earning (loss)

 

0.57

 

(0.87)

 

(2.93)

 

0.57

 

(0.87)

 

(2.93)

Loss per share—Diluted:

 

 

 

Net loss

 

(0.36)

 

(0.87)

 

(2.93)

 

(0.36)

 

(0.87)

 

(2.93)

During the year ended December 31, 2021, the Company issued 7,800,000 ordinary shares to its share depositary bank which will be used to settle stock option awards upon their exercise. No consideration was received by the Company for this issuance of ordinary shares. These ordinary shares are legally issued and outstanding but are treated as escrowed shares for accounting purposes and therefore, have been excluded from the computation of loss per share. Any ordinary shares not used in the settlement of stock option awards will be returned to the Company.

Stock options, RSUs, the Company’s 2025 Convertible Notes, 2026 Convertible Notes and 2027 Convertible Notes (Note 19) or other potentially dilutive equity instruments were excluded from the calculation of diluted loss earnings per share if they were anti-dilutive.